<?xml version="1.0" encoding="UTF-8"?>
<sigrec-multi-trials-transfert xmlns="http://sigrec.ClinicalTrialApplication.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://sigrec.ClinicalTrialApplication.xsd http://www.sigaps.fr/schema_echange/sigrec_XML_schemav0.68.xsd">
  <multi-trial>
    <trial trial-sigrec-identification="440000289_512" trial-interne-identification="" schemaversion="0.68">
      <sponsor-information>
        <sponsor node-id="440000289">
          <ev-sponsor-sender-id>440000289</ev-sponsor-sender-id>
          <sponsor-status/>
          <is-lead-sponsor>Y</is-lead-sponsor>
          <sponsor-type type-id="1">académique</sponsor-type>
          <sponsor-category cat-id="2">centre hospitalier</sponsor-category>
          <sponsor-contact-details>
            <organisation>C.H.U. DE NANTES</organisation>
            <given-name></given-name>
            <middle-name></middle-name>
            <family-name></family-name>
            <address>5 ALLEE DE L'ILE GLORIETTE BP 1005</address>
            <town-city>NANTES CEDEX 1</town-city>
            <post-code>44093</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>02 40 08 33 33</telephone>
            <fax>02 40 08 70 25</fax>
            <email></email>
          </sponsor-contact-details>
          <sponsor-intervenants/>
        </sponsor>
      </sponsor-information>
      <trial-identification>
        <eudract-number na="N">2010 021136-33</eudract-number>
        <full-title-trial>«Etude médicament de Phase II multicentrique, en ouvert, prospective non randomisée testant lintérêt dune combinaison de Chimio-immunothérapie comportant   lanticorps anti-CD22 Epratuzumab pour le traitement de patients adultes présentant une leucémie aigue lymphoblastique de type B CD22+ en rechute ou réfractaire : Etude CHEPRALL, une étude GRAALL»</full-title-trial>
        <sponsor-protocol-number>BRD 10/5-O</sponsor-protocol-number>
        <sponsor-protocol-version/>
        <sponsor-protocol-version-date/>
        <abbreviated-title-trial na="N">Etude CHEPRALL</abbreviated-title-trial>
        <ISRCTN-number/>
        <submission-member-state/>
        <submission-organisation-id/>
        <is-this-a-resubmission/>
        <resubmission-letter/>
        <is-there-a-placebo/>
      </trial-identification>
      <general-information>
        <summary-trial></summary-trial>
        <interventional-trial>Y</interventional-trial>
        <type-recherche>
          <recherche-biomédicale>Y</recherche-biomédicale>
          <soins-courants>N</soins-courants>
          <observationnelle>N</observationnelle>
          <sur-données>N</sur-données>
          <collections-biologiques>N</collections-biologiques>
        </type-recherche>
        <objet-recherche>
          <médicament>Y</médicament>
          <thérapie-cellulaire>N</thérapie-cellulaire>
          <thérapie-génétique>N</thérapie-génétique>
          <dm-implantable-actif>N</dm-implantable-actif>
          <dm-diagnostic-invitro>N</dm-diagnostic-invitro>
          <dm-autres>N</dm-autres>
          <thérapie-chirurgicale>N</thérapie-chirurgicale>
          <imagerie>N</imagerie>
          <radiothérapie>N</radiothérapie>
          <alicament>N</alicament>
          <nutrition>N</nutrition>
          <other>N</other>
        </objet-recherche>
        <trial-type-and-phase>
          <phase-one>N</phase-one>
          <phase-two>Y</phase-two>
          <phase-two-a>N</phase-two-a>
          <phase-two-b>N</phase-two-b>
          <phase-three>N</phase-three>
          <phase-four>N</phase-four>
          <first-human-administration/>
          <bioequivalence-study/>
          <other-phase/>
        </trial-type-and-phase>
        <trial-scope>
          <diagnosis/>
          <prophylaxis/>
          <therapy/>
          <safety/>
          <efficiacy/>
          <pharmacokinetic/>
          <pharmacodynamic/>
          <pharmacogenomic/>
          <pharmacogenetic/>
          <pharmacoeconomic/>
          <bioequivalence/>
          <dose-response/>
          <pharmacologie>N</pharmacologie>
          <thérapeutique>Y</thérapeutique>
          <pronostique>N</pronostique>
          <diagnostique>N</diagnostique>
          <physiologie>N</physiologie>
          <physiopathologie>N</physiopathologie>
          <prévention>N</prévention>
          <dépistage>N</dépistage>
          <génétique>N</génétique>
          <epidémiologie>N</epidémiologie>
          <other>N</other>
        </trial-scope>
        <discipline-information/>
        <medical-condition/>
        <ICD10-codeInformation/>
        <medDRA-codeInformation/>
        <trial-design>
          <single-site>N</single-site>
          <multiple-site>Y</multiple-site>
          <multiple-regional>N</multiple-regional>
          <multiple-interregional>N</multiple-interregional>
          <multiple-member-states>Y</multiple-member-states>
          <multiple-community>N</multiple-community>
          <third-countries>N</third-countries>
          <paris-idf>Y</paris-idf>
          <ouest>N</ouest>
          <nord-ouest>N</nord-ouest>
          <est>N</est>
          <sud-est>N</sud-est>
          <sud-méditerranée>N</sud-méditerranée>
          <sud-ouest>N</sud-ouest>
          <number-of-sites>10</number-of-sites>
          <number-of-sites-open></number-of-sites-open>
          <number-of-sites-member-states>10</number-of-sites-member-states>
          <number-of-sites-member-states-open></number-of-sites-member-states-open>
          <randomised>N</randomised>
          <controlled>N</controlled>
        </trial-design>
        <planned-start-date na="N">2010-10-27</planned-start-date>
        <planned-end-date na="N"/>
        <is-extension-end-date/>
        <extension-end-date xsi:nil="true"/>
        <total-trial-duration-ms-months na="N">29</total-trial-duration-ms-months>
        <total-trial-recruitment-duration-ms-months na="N"/>
        <funding-agency>
          <agency node-id="1">
            <code>1</code>
            <type>1202</type>
            <organization>PHRC national</organization>
            <funding-year>2010</funding-year>
          </agency>
        </funding-agency>
      </general-information>
      <regulatory-information>
        <initial-declaration>
          <tax>
            <sending-date xsi:nil="true"/>
            <receipt-date xsi:nil="true"/>
            <amount valeur-id=""></amount>
          </tax>
          <declaration-phase-information>
            <declaration-phase node-id="1">
              <sponsor-protocol-version na=""></sponsor-protocol-version>
              <sponsor-protocol-version-date>2010-06-18</sponsor-protocol-version-date>
              <sponsor-information-note-date xsi:nil="true"/>
              <sponsor-consentement-date>2010-09-02</sponsor-consentement-date>
              <ethics-committee-declaration>
                <reference-cpp></reference-cpp>
                <identity-ccpprb></identity-ccpprb>
                <identity-cpp valeur-id="706">CPP Ouest VI</identity-cpp>
                <admissibility-date na="N">2010-07-26</admissibility-date>
                <opinion-date>2010-09-09</opinion-date>
                <opinion>
                  <favorable/>
                  <favorable-avec-remarques/>
                  <complément-informations/>
                  <défavorable/>
                  <autre/>
                </opinion>
              </ethics-committee-declaration>
            </declaration-phase>
            <declaration-phase node-id="2">
              <sponsor-protocol-version na="N">1</sponsor-protocol-version>
              <sponsor-protocol-version-date>2010-06-18</sponsor-protocol-version-date>
              <sponsor-information-note-date>2010-06-18</sponsor-information-note-date>
              <sponsor-consentement-date>2010-09-02</sponsor-consentement-date>
              <ethics-committee-declaration>
                <reference-cpp></reference-cpp>
                <identity-ccpprb></identity-ccpprb>
                <identity-cpp valeur-id="706">CPP Ouest VI</identity-cpp>
                <admissibility-date na="N">2010-07-26</admissibility-date>
                <opinion-date>2010-09-09</opinion-date>
                <opinion>
                  <favorable>Y</favorable>
                  <favorable-avec-remarques>N</favorable-avec-remarques>
                  <complément-informations>N</complément-informations>
                  <défavorable>N</défavorable>
                  <autre>N</autre>
                </opinion>
              </ethics-committee-declaration>
            </declaration-phase>
            <declaration-phase node-id="3">
              <sponsor-protocol-version na="N">1</sponsor-protocol-version>
              <sponsor-protocol-version-date>2010-06-18</sponsor-protocol-version-date>
              <sponsor-information-note-date>2010-09-18</sponsor-information-note-date>
              <sponsor-consentement-date>2010-06-18</sponsor-consentement-date>
              <competent-authority-declaration>
                <ac-name id="1">AFSSAPS médicaments</ac-name>
                <admissibility-date>2010-08-17</admissibility-date>
                <closing-admissibility-date xsi:nil="true"/>
                <decision-date>2010-09-02</decision-date>
                <decision>
                  <autorisée>Y</autorisée>
                  <réserves>N</réserves>
                  <non-autorisée>N</non-autorisée>
                </decision>
              </competent-authority-declaration>
            </declaration-phase>
            <declaration-phase node-id="4">
              <sponsor-protocol-version na="N">1</sponsor-protocol-version>
              <sponsor-protocol-version-date>2010-06-18</sponsor-protocol-version-date>
              <sponsor-information-note-date>2010-06-18</sponsor-information-note-date>
              <sponsor-consentement-date>2010-06-18</sponsor-consentement-date>
              <competent-authority-declaration>
                <ac-name id="1">AFSSAPS médicaments</ac-name>
                <admissibility-date>2010-08-17</admissibility-date>
                <closing-admissibility-date xsi:nil="true"/>
                <decision-date>2010-09-02</decision-date>
                <decision>
                  <autorisée>Y</autorisée>
                  <réserves>N</réserves>
                  <non-autorisée>N</non-autorisée>
                </decision>
              </competent-authority-declaration>
            </declaration-phase>
          </declaration-phase-information>
        </initial-declaration>
        <amendement-information>
          <amendement-declaration node-id="1">
            <substantial-change>Y</substantial-change>
            <tax>
              <sending-date xsi:nil="true"/>
              <receipt-date xsi:nil="true"/>
              <amount valeur-id=""/>
            </tax>
            <amendment-type>
              <prolongation>N</prolongation>
              <nombre-de-sujets>N</nombre-de-sujets>
              <nouveau-centre>N</nouveau-centre>
              <protocole>Y</protocole>
              <info-consentement>N</info-consentement>
              <autre>N</autre>
            </amendment-type>
            <declaration-phase-information>
              <declaration-phase node-id="1">
                <sponsor-protocol-version na=""></sponsor-protocol-version>
                <sponsor-protocol-version-date>2010-11-15</sponsor-protocol-version-date>
                <sponsor-information-note-date xsi:nil="true"/>
                <sponsor-consentement-date>2010-11-15</sponsor-consentement-date>
                <ethics-committee-declaration>
                  <reference-cpp>655</reference-cpp>
                  <identity-ccpprb></identity-ccpprb>
                  <identity-cpp valeur-id=""></identity-cpp>
                  <admissibility-date xsi:nil="true" na=""/>
                  <opinion-date>2010-12-15</opinion-date>
                  <opinion>
                    <favorable/>
                    <favorable-avec-remarques/>
                    <complément-informations/>
                    <défavorable/>
                    <autre/>
                  </opinion>
                </ethics-committee-declaration>
              </declaration-phase>
              <declaration-phase node-id="2">
                <sponsor-protocol-version na=""></sponsor-protocol-version>
                <sponsor-protocol-version-date>2010-11-15</sponsor-protocol-version-date>
                <sponsor-information-note-date xsi:nil="true"/>
                <sponsor-consentement-date>2010-11-15</sponsor-consentement-date>
                <ethics-committee-declaration>
                  <reference-cpp>655</reference-cpp>
                  <identity-ccpprb></identity-ccpprb>
                  <identity-cpp valeur-id=""></identity-cpp>
                  <admissibility-date xsi:nil="true" na=""/>
                  <opinion-date>2010-12-15</opinion-date>
                  <opinion>
                    <favorable/>
                    <favorable-avec-remarques/>
                    <complément-informations/>
                    <défavorable/>
                    <autre/>
                  </opinion>
                </ethics-committee-declaration>
              </declaration-phase>
              <declaration-phase node-id="3">
                <sponsor-protocol-version na=""></sponsor-protocol-version>
                <sponsor-protocol-version-date>2010-11-15</sponsor-protocol-version-date>
                <sponsor-information-note-date xsi:nil="true"/>
                <sponsor-consentement-date>2010-11-15</sponsor-consentement-date>
                <competent-authority-declaration>
                  <ac-name id=""></ac-name>
                  <admissibility-date xsi:nil="true"/>
                  <closing-admissibility-date xsi:nil="true"/>
                  <decision-date xsi:nil="true"/>
                  <decision>
                    <autorisée/>
                    <réserves/>
                    <non-autorisée/>
                  </decision>
                </competent-authority-declaration>
              </declaration-phase>
              <declaration-phase node-id="4">
                <sponsor-protocol-version na=""></sponsor-protocol-version>
                <sponsor-protocol-version-date>2010-11-15</sponsor-protocol-version-date>
                <sponsor-information-note-date xsi:nil="true"/>
                <sponsor-consentement-date>2010-11-15</sponsor-consentement-date>
                <competent-authority-declaration>
                  <ac-name id=""></ac-name>
                  <admissibility-date xsi:nil="true"/>
                  <closing-admissibility-date xsi:nil="true"/>
                  <decision-date>2010-11-26</decision-date>
                  <decision>
                    <autorisée/>
                    <réserves/>
                    <non-autorisée/>
                  </decision>
                </competent-authority-declaration>
              </declaration-phase>
            </declaration-phase-information>
          </amendement-declaration>
        </amendement-information>
        <communication-information>
          <cpp-first-inclusion-date xsi:nil="true"/>
          <cpp-last-patient-information-date xsi:nil="true"/>
          <cpp-sending-date xsi:nil="true"/>
          <ac-first-inclusion-date xsi:nil="true"/>
          <ac-last-patient-information-date xsi:nil="true"/>
          <ac-sending-date xsi:nil="true"/>
        </communication-information>
        <insurance-information/>
        <cnil/>
        <cro/>
      </regulatory-information>
      <proposed-clinical-trial-sites>
        <investigator inv-id="1">
          <sponsor-investigator-number>1</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>440000289</institution-finess>
          <institution-name>C.H.U. DE NANTES</institution-name>
          <contact-details>
            <organisation>440000289</organisation>
            <given-name>Patrice</given-name>
            <middle-name></middle-name>
            <family-name>CHEVALLIER</family-name>
            <service>CLINIQUE D'HEMATOLOGIE HD</service>
            <address>5 ALLEE DE L'ILE GLORIETTE BP 1005</address>
            <town-city>NANTES CEDEX 1</town-city>
            <post-code>44093</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>02 40 08 33 33</telephone>
            <fax>02 40 08 70 25</fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="68530">
              <id>824</id>
              <titre></titre>
              <nom>CHEVALLIER</nom>
              <prenom>Patrice</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>102</fonction-id>
                <fonction-libelle>Investigateur coordonnateur</fonction-libelle>
              </fonctions>
              <service>
                <id>243</id>
                <libelle>CLINIQUE D'HEMATOLOGIE HD</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees/>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>CLINIQUE D'HEMATOLOGIE HD</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information>
            <inclusion-cumulation cumul-id="129372">
              <is-use-for-export>N</is-use-for-export>
              <cumulation-begining-date>2010-10-19</cumulation-begining-date>
              <cumulation-end-date>2010-12-31</cumulation-end-date>
              <cumulation-number>4</cumulation-number>
            </inclusion-cumulation>
          </inclusion-cumulation-information>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="2">
          <sponsor-investigator-number>2</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>490000031</institution-finess>
          <institution-name>C.H.U. D' ANGERS</institution-name>
          <contact-details>
            <organisation>490000031</organisation>
            <given-name>Mathilde</given-name>
            <middle-name></middle-name>
            <family-name>HUNAULT-BERGER</family-name>
            <service>Maladies du sang</service>
            <address>4 RUE LARREY </address>
            <town-city>ANGERS CEDEX 9</town-city>
            <post-code>49933</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>02 41 35 36 37</telephone>
            <fax>02 41 35 55 06</fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="88840">
              <id>418</id>
              <titre></titre>
              <nom>HUNAULT-BERGER</nom>
              <prenom>Mathilde</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>140</id>
                <libelle>Maladies du sang</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2056677</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
            <intervenant intervenant-id="88839">
              <id>769</id>
              <titre></titre>
              <nom>MARIE</nom>
              <prenom>Céline</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>104</fonction-id>
                <fonction-libelle>ARC-Investigateur (TRC/TEC)</fonction-libelle>
              </fonctions>
              <service>
                <id>140</id>
                <libelle>Maladies du sang</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2057721</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>Maladies du sang</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information/>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="3">
          <sponsor-investigator-number>3</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>750100075</institution-finess>
          <institution-name>HOPITAL SAINT-LOUIS (AP-HP)</institution-name>
          <contact-details>
            <organisation>750100075</organisation>
            <given-name>herve</given-name>
            <middle-name></middle-name>
            <family-name>dombret</family-name>
            <service>HEMATOLOGIE AD (SLS)</service>
            <address>1 AVENUE CLAUDE VELLEFAUX </address>
            <town-city>PARIS CEDEX 10</town-city>
            <post-code>75475</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>01 42 49 49 49</telephone>
            <fax>01 42 49 99 54</fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="75810">
              <id>27107</id>
              <titre></titre>
              <nom>dombret</nom>
              <prenom>herve</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>947</id>
                <libelle>HEMATOLOGIE AD (SLS)</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2056771</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>HEMATOLOGIE AD (SLS)</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information/>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="4">
          <sponsor-investigator-number>4</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>330783648</institution-finess>
          <institution-name>HOPITAL DE HAUT LEVEQUE</institution-name>
          <contact-details>
            <organisation>330783648</organisation>
            <given-name>Thibaut</given-name>
            <middle-name></middle-name>
            <family-name>LEGUAY</family-name>
            <service>HL PR MILPIED G6</service>
            <address>AVENUE DE MAGELLAN </address>
            <town-city>PESSAC CEDEX</town-city>
            <post-code>33604</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>05 56 55 65 65</telephone>
            <fax></fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="80458">
              <id>259</id>
              <titre></titre>
              <nom>LEGUAY</nom>
              <prenom>Thibaut</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>3125</id>
                <libelle>HL PR MILPIED G6</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2038364</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
            <intervenant intervenant-id="80457">
              <id>2295</id>
              <titre></titre>
              <nom>SAUVEZIE</nom>
              <prenom>Mathieu</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>104</fonction-id>
                <fonction-libelle>ARC-Investigateur (TRC/TEC)</fonction-libelle>
              </fonctions>
              <service>
                <id>3356</id>
                <libelle>RC ESSAIS CLINIQUES</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2053334</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>HL PR MILPIED G6</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information/>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="5">
          <sponsor-investigator-number>5</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>690783154</institution-finess>
          <institution-name>HOPITAL EDOUARD HERRIOT</institution-name>
          <contact-details>
            <organisation>690783154</organisation>
            <given-name>Xavier</given-name>
            <middle-name></middle-name>
            <family-name>THOMAS</family-name>
            <service>HEMATO. PAV.E</service>
            <address>5 PLACE D'ARSONVAL </address>
            <town-city>LYON CEDEX 03</town-city>
            <post-code>69437</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>04 72 11 73 11</telephone>
            <fax>04 72 11 10 25</fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="89964">
              <id>2517</id>
              <titre></titre>
              <nom>THOMAS</nom>
              <prenom>Xavier</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>290</id>
                <libelle>HEMATO. PAV.E</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2056723</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>HEMATO. PAV.E</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information/>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="6">
          <sponsor-investigator-number>6</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>310783048</institution-finess>
          <institution-name>HOPITAL DE PURPAN CHU TOULOUSE</institution-name>
          <contact-details>
            <organisation>310783048</organisation>
            <given-name>Francoise</given-name>
            <middle-name></middle-name>
            <family-name>HUGUET</family-name>
            <service>Service d'hématologie clinique</service>
            <address>1 PLACE DU DOCTEUR BAYLAC TSA 400 31</address>
            <town-city>TOULOUSE CEDEX 9</town-city>
            <post-code>31059</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>05 61 77 22 33</telephone>
            <fax></fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="68534">
              <id>824</id>
              <titre></titre>
              <nom>HUGUET</nom>
              <prenom>Francoise</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>218</id>
                <libelle>Service d'hématologie clinique</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2056797</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>Service d'hématologie clinique</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information>
            <inclusion-cumulation cumul-id="129373">
              <is-use-for-export>N</is-use-for-export>
              <cumulation-begining-date>2010-10-27</cumulation-begining-date>
              <cumulation-end-date>2010-12-31</cumulation-end-date>
              <cumulation-number>1</cumulation-number>
            </inclusion-cumulation>
          </inclusion-cumulation-information>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="7">
          <sponsor-investigator-number>7</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>SIR_INDUSTRIELS_146</institution-finess>
          <institution-name>Hôpital Henri Mondor</institution-name>
          <contact-details>
            <organisation>SIR_INDUSTRIELS_146</organisation>
            <given-name>Sébastien</given-name>
            <middle-name></middle-name>
            <family-name>MAURY</family-name>
            <service>Hématologie Clinique</service>
            <address>51, avenue du Maréchal de Lattre de Tassigny</address>
            <town-city>Créteil</town-city>
            <post-code>94010</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone></telephone>
            <fax></fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="68535">
              <id>48798</id>
              <titre></titre>
              <nom>MAURY</nom>
              <prenom>Sébastien</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>N</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>31093</id>
                <libelle>Hématologie Clinique</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>N</consolidation>
                <coordonnees>
                  <organisation>2025536</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>Hématologie Clinique</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information/>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="8">
          <sponsor-investigator-number>8</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>750100208</institution-finess>
          <institution-name>HOPITAL NECKER ENFANTS MALADES (AP-HP)</institution-name>
          <contact-details>
            <organisation>750100208</organisation>
            <given-name>agnes</given-name>
            <middle-name></middle-name>
            <family-name>buzyn levy</family-name>
            <service>HEMATO.CLI.ADULTES (NCK)</service>
            <address>149 RUE DE SEVRES </address>
            <town-city>PARIS CEDEX 15</town-city>
            <post-code>75743</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>01 44 49 40 00</telephone>
            <fax>01 44 49 41 15</fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="75809">
              <id>26027</id>
              <titre></titre>
              <nom>buzyn levy</nom>
              <prenom>agnes</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>677</id>
                <libelle>HEMATO.CLI.ADULTES (NCK)</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2056799</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>HEMATO.CLI.ADULTES (NCK)</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information/>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="10">
          <sponsor-investigator-number>9</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>140000100</institution-finess>
          <institution-name>CHU COTE DE NACRE - CAEN</institution-name>
          <contact-details>
            <organisation>140000100</organisation>
            <given-name>Oumedaly</given-name>
            <middle-name></middle-name>
            <family-name>REMAN</family-name>
            <service>HEMATOLOGIE CLINIQUE</service>
            <address>AVENUE DE LA COTE DE NACRE </address>
            <town-city>CAEN CEDEX 5</town-city>
            <post-code>14033</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>02 31 06 31 06</telephone>
            <fax>02 31 06 47 70</fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="68538">
              <id>521</id>
              <titre></titre>
              <nom>REMAN</nom>
              <prenom>Oumedaly</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>131</id>
                <libelle>HEMATOLOGIE CLINIQUE</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2056706</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>HEMATOLOGIE CLINIQUE</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information/>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
        <investigator inv-id="9">
          <sponsor-investigator-number>10</sponsor-investigator-number>
          <type-investigator type-id="1">Centre recruteur</type-investigator>
          <institution-finess>130784127</institution-finess>
          <institution-name>INSTITUT PAOLI CALMETTES</institution-name>
          <contact-details>
            <organisation>130784127</organisation>
            <given-name>Norbert</given-name>
            <middle-name></middle-name>
            <family-name>VEY</family-name>
            <service>IPC - Onco Hématologie</service>
            <address>232 BOULEVARD SAINTE MARGUERITE BP 156</address>
            <town-city>MARSEILLE CEDEX 09</town-city>
            <post-code>13273</post-code>
            <country-iso-code>France</country-iso-code>
            <telephone>04 91 22 33 33</telephone>
            <fax>04 91 22 34 44</fax>
            <email></email>
          </contact-details>
          <investigator-progress>
            <trial-interne-identification></trial-interne-identification>
            <date-receipt-protocole xsi:nil="true"/>
            <date-signing-agreement xsi:nil="true"/>
            <agreement-signatory id=""/>
            <actual-start-date xsi:nil="true"/>
            <actual-end-date xsi:nil="true"/>
            <date-place xsi:nil="true"/>
            <date-last-inclusion xsi:nil="true"/>
            <closing-date xsi:nil="true"/>
            <planned-number></planned-number>
            <study-state/>
          </investigator-progress>
          <intervenants>
            <intervenant intervenant-id="78164">
              <id>704</id>
              <titre></titre>
              <nom>VEY</nom>
              <prenom>Norbert</prenom>
              <civilite></civilite>
              <num-adeli></num-adeli>
              <consolidation>Y</consolidation>
              <fonctions>
                <fonction-id>101</fonction-id>
                <fonction-libelle>Investigateur principal</fonction-libelle>
              </fonctions>
              <service>
                <id>760</id>
                <libelle>IPC - Onco Hématologie</libelle>
                <date-arrivee xsi:nil="true"/>
                <date-depart xsi:nil="true"/>
                <consolidation>Y</consolidation>
                <coordonnees>
                  <organisation>2056734</organisation>
                  <given-name></given-name>
                  <middle-name></middle-name>
                  <family-name></family-name>
                  <service></service>
                  <address></address>
                  <town-city></town-city>
                  <post-code></post-code>
                  <country-iso-code></country-iso-code>
                  <telephone></telephone>
                  <fax></fax>
                  <email></email>
                </coordonnees>
              </service>
            </intervenant>
          </intervenants>
          <institution-department>IPC - Onco Hématologie</institution-department>
          <institution-participation/>
          <investigator-participation/>
          <inclusion-cumulation-information/>
          <inclusions/>
          <investigator-qualification/>
        </investigator>
      </proposed-clinical-trial-sites>
      <dispositif-medical-information/>
      <medicinal-products>
        <medicinal-product node-id="1">
          <code>Epratuzumab</code>
          <name></name>
          <ATC-code></ATC-code>
        </medicinal-product>
      </medicinal-products>
      <population-of-trial-subjects>
        <planned-numbers>
          <in-whole-trial>55</in-whole-trial>
          <in-member-state>55</in-member-state>
        </planned-numbers>
        <age>
          <age-unit>
            <jours>N</jours>
            <semaines>N</semaines>
            <mois>N</mois>
            <années>Y</années>
          </age-unit>
          <min-age na="">18</min-age>
          <max-age na=""></max-age>
          <under-eighteen/>
          <adult/>
          <elderly/>
          <in-utero>N</in-utero>
          <preterm-newborn-infants>N</preterm-newborn-infants>
          <newborn>N</newborn>
          <infant-and-toddler>N</infant-and-toddler>
          <children>N</children>
          <adolescent>N</adolescent>
        </age>
        <healthy-volunteers>N</healthy-volunteers>
        <patients>Y</patients>
        <is-there-a-population-of-trial>N</is-there-a-population-of-trial>
        <gender-male>N</gender-male>
        <gender-female>Y</gender-female>
        <women-of-child-bearing-potential/>
        <women-of-child-bearing-contraception/>
        <pregnant-women/>
        <nursing-women/>
        <emergency-situation/>
        <subjects-incapable-of-consent/>
        <other-patient/>
      </population-of-trial-subjects>
    </trial>
  </multi-trial>
</sigrec-multi-trials-transfert>
